English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/103232
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


A fluorescent styrylquinoline with combined therapeutic and diagnostic activities against Alzheimer's and prion diseases

AuthorsStaderini, Matteo; Aulic, Suzana; Bartolini, Manuela; Tran, H. N. A.; González-Ruiz, Victor; Pérez, Daniel I.; Cabezas, Nieves; Martínez, Ana ; Martín, M. Antonia; Andrisano, Vincenza; Legname, Giuseppe; Menéndez, J. Carlos; Bolognesi, Maria Laura
Issue Date2013
PublisherAmerican Chemical Society
CitationACS Medicinal Chemistry Letters 4: 225- 229 (2013)
Abstract(E)-6-Methyl-4′-amino-2-styrylquinoline (3) is a small molecule with the proper features to potentially diagnose, deliver therapy and monitor response to therapy in protein misfolding diseases. These features include compound fluorescent emission in the NIR region and its ability to interact with both Aβ and prion fibrils, staining them with high selectivity. Styrylquinoline 3 also inhibits Aβ self-aggregation in vitro and prion replication in the submicromolar range in a cellular context. Furthermore, it is not toxic and is able to cross the blood brain barrier in vitro (PAMPA test).
Identifiersdoi: 10.1021/ml3003605
issn: 1948-5875
e-issn: 1948-5875
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.